Page last updated: 2024-11-02

pentoxifylline and Corneal Neovascularization

pentoxifylline has been researched along with Corneal Neovascularization in 1 studies

Corneal Neovascularization: New blood vessels originating from the corneal blood vessels and extending from the limbus into the adjacent CORNEAL STROMA. Neovascularization in the superficial and/or deep corneal stroma is a sequel to numerous inflammatory diseases of the ocular anterior segment, such as TRACHOMA, viral interstitial KERATITIS, microbial KERATOCONJUNCTIVITIS, and the immune response elicited by CORNEAL TRANSPLANTATION.

Research Excerpts

ExcerptRelevanceReference
", 1991), we found that pentoxifylline and thalidomide potentiate each others antiangiogenic effect induced by human malignant melanoma cells in the cornea of Macaca arctoides monkeys."3.70Study of antiangiogenic agents with possible therapeutic applications in neoplastic disorders and macular degeneration. ( Akhter, S; Ambrus, JL; Karakousis, CP; Kulaylat, M; Plavsic, L; Toumbis, CA, 2000)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ambrus, JL1
Toumbis, CA1
Karakousis, CP1
Kulaylat, M1
Akhter, S1
Plavsic, L1

Other Studies

1 other study available for pentoxifylline and Corneal Neovascularization

ArticleYear
Study of antiangiogenic agents with possible therapeutic applications in neoplastic disorders and macular degeneration.
    Journal of medicine, 2000, Volume: 31, Issue:5-6

    Topics: Angiogenesis Inhibitors; Animals; Cells, Cultured; Cornea; Corneal Neovascularization; Drug Combinat

2000